Author

Michal Lichtenstein

Hebrew University of Jerusalem

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Organism:human· 1 Approach:statistical model· 1

Frequent Co-Authors

Abdelrahaman KarmiiD· 1 shared Anees KhatibiD· 1 shared Arata HayashiiD· 1 shared Areej Abu RmailehiD· 1 shared Balakrishnan SolaimuthuiD· 1 shared Itai MizrahiiD· 1 shared Ora Schueler‐FurmaniD· 1 shared Ravit Glukhman· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Abdelrahaman KarmiORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Dihydropyrimidines sustain aggressive cancer states by stabilizing DPYSL2

Arata Hayashi, Sarah Knapp, Abdelrahaman Karmi, Vaibhav Gupta, Itai Mizrahi, Shirel Lavi, Sinai Shammah, Yael Sitton, Ravit Glukhman, Balakrishnan Solaimuthu, Sayanika Banerjee, Areej Abu Rmaileh, Anees Khatib, Michal Lichtenstein, Ora Schueler‐Furman, , Yoav David Shaul

This study identifies dihydropyrimidines (DHPs) as signaling metabolites that sustain aggressive cancer states by stabilizing DPYSL2, linking metabolic activity to oncogenic signaling.

bioRxiv · Jun 18, 2026 · PreprintCancer Biology